LDL Is Not the Enemy: Why Particle Count Matters More Than Total Number

The anti-statin crowd points out correctly that LDL cholesterol is "not the full story" and that lots of men with normal LDL have heart attacks. The correct conclusion from this — that LDL-C alone is inadequate for cardiovascular risk assessment — often gets taken the wrong direction, into "so cholesterol doesn't matter." That's not where the data leads.

The data leads to particle count. Specifically, the number of atherogenic particles (measured by ApoB or LDL-P) in your blood is what physically causes atherosclerosis. LDL-C is a proxy for that number that's accurate most of the time and misleading maybe 20% of the time. The problem isn't LDL; it's the measurement.

How Particles Actually Cause Disease

Atherosclerosis isn't "cholesterol clogging arteries." The mechanism is that lipoprotein particles — LDL, VLDL, IDL, Lp(a) — penetrate the arterial wall, get retained there, get oxidized by local inflammatory conditions, and trigger immune responses that form plaque over years.

Whether a particle penetrates the wall depends on particle characteristics (size, modification state) and wall conditions (inflammation, endothelial dysfunction). But the probability of any individual particle penetrating is roughly constant per particle. So: more particles in your blood = more particles entering your wall = more atherosclerosis over decades.

This is why particle count is the causal variable. LDL-C is a correlated quantity that usually tracks particle count but sometimes doesn't.

When LDL-C and Particle Count Diverge

LDL particles vary in size. A small dense LDL particle carries less cholesterol than a large buoyant one. Two patterns:

Pattern A: Few large buoyant particles, each carrying lots of cholesterol. LDL-C is high, particle count is moderate. Cardiovascular risk is lower than the LDL-C suggests.

Pattern B: Many small dense particles, each carrying less cholesterol. LDL-C looks normal, particle count is high. Cardiovascular risk is worse than LDL-C suggests.

Pattern B is common in:

• Insulin resistance / metabolic syndrome
• Type 2 diabetes
• Obesity
• Elevated triglycerides with low HDL pattern
• Some genetic dyslipidemias

A man with an LDL-C of 115 and fasting triglycerides of 200 and low HDL is classically Pattern B. His LDL-C doesn't capture his actual risk. His ApoB or LDL-P will.

LDL-P vs ApoB: Which to Order

Two tests measure particle count:

LDL-P (nuclear magnetic resonance or similar). Measures the number of LDL particles directly. Historical gold standard for particle count.

ApoB. Measures ApoB-100 protein, which equates 1:1 with atherogenic particles (including LDL, VLDL, and IDL — so it's actually more comprehensive than LDL-P alone).

ApoB is cheaper, more widely available, standardized across labs, and measures the full atherogenic particle count. LDL-P measures LDL specifically with higher resolution but isn't as broadly accessible.

For clinical use, ApoB is the pragmatic choice. Order it.

HDL: The Less Simple Story

HDL cholesterol was long considered the "good cholesterol." Higher HDL was thought to be cardioprotective, and drugs raising HDL were pursued for decades. Then, in rapid succession, CETP inhibitors failed to reduce cardiovascular events despite raising HDL, Mendelian randomization studies found that genetic variants raising HDL did NOT reduce risk, and the whole narrative fell apart.

Current understanding: HDL function (how well HDL particles actually do their reverse cholesterol transport job) matters more than HDL quantity. Very low HDL (under 40 mg/dL) is associated with increased risk, but above that, raising HDL doesn't seem to help. Extremely high HDL (above 90) may actually be associated with increased risk in some cohorts.

Practical implication: don't chase HDL. Low HDL usually indicates metabolic problems (insulin resistance, obesity) that should be addressed; the low HDL is a symptom, not a standalone target.

Triglycerides: The Underrated Marker

Elevated triglycerides indicate excess VLDL production, typically driven by insulin resistance and excess carbohydrate intake. High triglycerides are themselves mildly atherogenic (VLDL carries ApoB), and they drive the formation of small dense LDL.

Optimal fasting triglycerides: under 100 mg/dL. Borderline: 100-150. High: over 150. Very high (over 500) is a separate category with pancreatitis risk.

Triglycerides respond strongly to lifestyle — weight loss, reduced refined carbs and alcohol, omega-3 supplementation, exercise. A man whose triglycerides drop from 180 to 90 has likely meaningfully reduced his small dense LDL burden.

The Total Cholesterol Number

Total cholesterol (TC) is LDL-C + HDL-C + (triglycerides/5). It's the first number printed on your lab report and usually the one your doctor emphasizes. It's also the least useful of the basic lipid panel — you can have high TC from high HDL (possibly fine) or from high LDL (concerning). TC alone doesn't tell you which.

Ignore total cholesterol if the other numbers are available. It's a holdover from when measuring the components was harder than measuring the sum.

Non-HDL Cholesterol

Total cholesterol minus HDL cholesterol. Captures all atherogenic cholesterol (LDL-C + VLDL-C) in a single number. Easier to calculate than ApoB (needs only standard panel) and better than LDL-C alone because it includes VLDL.

Optimal: under 130 mg/dL. Non-HDL above 150-160 warrants attention regardless of LDL-C alone.

The Pattern That Tells You Something

Look at your whole panel together, not one number in isolation. A few patterns to recognize:

Healthy pattern: LDL-C 80-130, HDL 45-70, triglycerides under 100, ApoB under 90. Low risk.

Classic metabolic syndrome pattern: LDL-C borderline (100-140), HDL low (under 40), triglycerides elevated (over 150), ApoB elevated. Higher risk than LDL-C suggests. Also often associated with elevated fasting insulin, waist circumference, and blood pressure.

Familial hypercholesterolemia pattern: LDL-C very high (over 190), early family history of cardiovascular disease, often normal or low triglycerides. Genetic condition that warrants aggressive treatment.

Lean hyper-responder pattern: Low-carb dieter with high LDL-C and ApoB but high HDL, low triglycerides, lean body composition. Risk implications debated but not obviously benign — monitoring and risk discussion warranted.

What to Do With the Information

Get the comprehensive panel. ApoB + standard lipids + triglycerides + fasting insulin. Track year over year. Identify which pattern you're in.

If atherogenic markers are elevated:

• Address the underlying drivers (weight, insulin resistance, alcohol, diet quality)
• Reassess after 3-6 months of consistent lifestyle intervention
• If still elevated and risk is meaningful, consider medication with your doctor
• Don't wait for a cardiovascular event to be the trigger

If atherogenic markers are normal:

• Great; stay there
• Annual retesting to catch drift
• Don't over-optimize if you're already in good range

The Bottom Line

LDL cholesterol matters, but not because cholesterol itself is the enemy — because cholesterol mass tracks (imperfectly) with particle count, and particle count is what drives the disease. If you want to know what's actually happening in your arteries, measure the particles directly. ApoB is that measurement, it's available, it's cheap, and most men aren't getting it.

If your next blood panel doesn't include ApoB, that's a gap in your cardiovascular assessment worth closing.